Vertaling van "screening mammography " (Nederlands → Frans) :

TERMINOLOGIE

screening van zuigeling voorafgaand aan ontslag
dépistage d'un nourrisson avant la sortie de l'hôpital

screening naar alcoholmisbruik
dépistage d'une surconsommation d'alcool

screening naar middelenmisbruik
dépistage d'une surconsommation de substances

screening naar gehoorverlies
dépistage d'une perte d'audition

screening naar drugmisbruik
dépistage d'une surconsommation de drogues

screening naar ontwikkeling van kind
dépistage du développement d'un enfant

screening naar misbruik
dépistage d'une maltraitance

screening naar depressie
dépistage de la dépression

screening naar immunisatiestatus
dépistage de l'état de l'immunisation

screening naar ontwikkeling van zuigeling
dépistage du développement du nourrisson

IN-CONTEXT TRANSLATIONS

40. Theberge I, Hebert-Croteau N, Langlois A, Major D, Brisson J. Volume of screening mammography and performance in the Quebec population-based Breast Cancer Screening Program.
39. Theberge I, Hebert-Croteau N, Langlois A, Major D, Brisson J. Volume of screening mammography and performance in the Quebec population-based Breast Cancer Screening Program.

55. Mandelblatt J, Saha S, Teutsch S, Hoerger T, Siu AL, Atkins D, et al. The costeffectiveness of screening mammography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force.
54. Mandelblatt J, Saha S, Teutsch S, Hoerger T, Siu AL, Atkins D, et al. The costeffectiveness of screening mammography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force.

56. Kerlikowske K, Salzmann P, Phillips KA, Cauley JA, Cummings SR. Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.
55. Kerlikowske K, Salzmann P, Phillips KA, Cauley JA, Cummings SR. Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.

48. Smith-Bindman R, Kerlikowske K, Gebretsadik T, Newman J. Is screening mammography effective in elderly women?
47. Smith-Bindman R, Kerlikowske K, Gebretsadik T, Newman J. Is screening mammography effective in elderly women?

42. Kerlikowske K, Grady D, Barclay J, Sickles EA, Eaton A, Ernster V. Positive predictive value of screening mammography by age and family history of breast cancer.
41. Kerlikowske K, Grady D, Barclay J, Sickles EA, Eaton A, Ernster V. Positive predictive value of screening mammography by age and family history of breast cancer.

39. Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography.
40. Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography.

12. Ringash J. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
13. Ringash J. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.